Title: Cangrelor: A Review in Percutaneous Coronary Intervention.
Journal: Drugs 20150801
Title: Overview of the 2014 Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee meeting regarding cangrelor.
Journal: The American journal of cardiology 20150415
Title: Cangrelor: an emerging therapeutic option for patients with coronary artery disease.
Journal: Current medical research and opinion 20140501
Title: Effects on platelet function of a direct acting antagonist of coagulation factor Xa.
Journal: Journal of thrombosis and thrombolysis 20121001
Title: Evaluation of ticagrelor pharmacodynamic interactions with reversibly binding or non-reversibly binding P2Y(12) antagonists in an ex-vivo canine model.
Journal: Thrombosis research 20121001
Title: Advances in antiplatelet therapy for acute coronary syndromes.
Journal: Postgraduate medical journal 20120701
Title: Synthesis of N6-alkyl(aryl)-2-alkyl(aryl)thioadenosines as antiplatelet agents.
Journal: European journal of medicinal chemistry 20120701
Title: Pharmacodynamic effects of cangrelor and clopidogrel: the platelet function substudy from the cangrelor versus standard therapy to achieve optimal management of platelet inhibition (CHAMPION) trials.
Journal: Journal of thrombosis and thrombolysis 20120701
Title: Short-acting P2Y12 blockade to reduce platelet dysfunction and coagulopathy during experimental extracorporeal circulation and hypothermia.
Journal: British journal of anaesthesia 20120601
Title: Rationale and design of the Cangrelor versus standard therapy to acHieve optimal Management of Platelet InhibitiON PHOENIX trial.
Journal: American heart journal 20120501
Title: Reduced immediate ischemic events with cangrelor in PCI: a pooled analysis of the CHAMPION trials using the universal definition of myocardial infarction.
Journal: American heart journal 20120201
Title: Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial.
Journal: JAMA 20120118
Title: Thienopyridines and other ADP-receptor antagonists.
Journal: Handbook of experimental pharmacology 20120101
Title: The P2Y(12) antagonists, 2MeSAMP and cangrelor, inhibit platelet activation through P2Y(12)/G(i)-dependent mechanism.
Journal: PloS one 20120101
Title: BF061, a novel antiplatelet and antithrombotic agent targeting P2Y₁₂ receptor and phosphodiesterase.
Journal: Thrombosis and haemostasis 20111201
Title: Nucleotides control the excitability of sensory neurons via two P2Y receptors and a bifurcated signaling cascade.
Journal: Pain 20110801
Title: Beyond aspirin and clopidogrel: is there a need for additional antiplatelet therapy in ACS?
Journal: Current cardiology reports 20110801
Title: [ADP receptor blockers: new insights in the therapy and prophylaxis of ischemic heart disease].
Journal: Deutsche medizinische Wochenschrift (1946) 20110701
Title: [Myocardial infarction: Role of new antiplatelet agents].
Journal: Presse medicale (Paris, France : 1983) 20110601
Title: [Update on anti-platelet therapy].
Journal: Deutsche medizinische Wochenschrift (1946) 20110601
Title: [New approaches and indications for the analysis of platelet function in cardiology].
Journal: Hamostaseologie 20110502
Title: High residual platelet reactivity on standard clopidogrel maintenance dose predicts increased responsiveness to the double-standard dose in an assay-dependent manner.
Journal: Thrombosis and haemostasis 20110501
Title: Bleeding manifestations of congenital and drug-induced defects of the platelet P2Y12 receptor for adenosine diphosphate.
Journal: Thrombosis and haemostasis 20110501
Title: Pharmacology and clinical trials of reversibly-binding P2Y12 inhibitors.
Journal: Thrombosis and haemostasis 20110501
Title: Comparison of the VASP assay and platelet aggregometry in the evaluation of platelet P2Y12 receptor blockade.
Journal: Polskie Archiwum Medycyny Wewnetrznej 20110401
Title: [Recent advances on the studies of the platelet's inhibition and aggregation. State of the art of new P2Y12 antagonists].
Journal: Recenti progressi in medicina 20110401
Title: Adenosine derived from ADP can contribute to inhibition of platelet aggregation in the presence of a P2Y12 antagonist.
Journal: Arteriosclerosis, thrombosis, and vascular biology 20110201
Title: The new INNOVANCE® PFA P2Y cartridge is sensitive to the detection of the P2Y₁₂ receptor inhibition.
Journal: Platelets 20110101
Title: Mode of action of P2Y(12 ) antagonists as inhibitors of platelet function.
Journal: Thrombosis and haemostasis 20110101
Title: P2Y₁₂ and EP3 antagonists promote the inhibitory effects of natural modulators of platelet aggregation that act via cAMP.
Journal: Platelets 20110101
Title: Platelet adhesion and degranulation induce pro-survival and pro-angiogenic signalling in ovarian cancer cells.
Journal: PloS one 20110101
Title: Nerve injury-activated microglia engulf myelinated axons in a P2Y12 signaling-dependent manner in the dorsal horn.
Journal: Glia 20101115
Title: SCH 602539, a protease-activated receptor-1 antagonist, inhibits thrombosis alone and in combination with cangrelor in a Folts model of arterial thrombosis in cynomolgus monkeys.
Journal: Arteriosclerosis, thrombosis, and vascular biology 20101101
Title: Mutational analysis of residues important for ligand interaction with the human P2Y(12) receptor.
Journal: European journal of pharmacology 20101010
Title: State of the art of new P2Y12 antagonists.
Journal: Internal and emergency medicine 20101001
Title: Enhanced platelet reactivity and thrombosis in Apoe-/- mice exposed to cigarette smoke is attenuated by P2Y12 antagonism.
Journal: Thrombosis research 20101001
Title: BF0801, a novel adenine derivative, inhibits platelet activation via phosphodiesterase inhibition and P2Y12 antagonism.
Journal: Thrombosis and haemostasis 20101001
Title: P2Y13 receptor is critical for reverse cholesterol transport.
Journal: Hepatology (Baltimore, Md.) 20101001
Title: Update on the clinical development of cangrelor.
Journal: Expert review of cardiovascular therapy 20100801
Title: Antagonism of P2Y12 or GPIIb/IIIa receptors reduces platelet-mediated myocardial injury after ischaemia and reperfusion in isolated rat hearts.
Journal: Thrombosis and haemostasis 20100701
Title: [Novel agents in antiplatelet therapy].
Journal: Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir 20100701
Title: Frontal affinity chromatography-mass spectrometry useful for characterization of new ligands for GPR17 receptor.
Journal: Journal of medicinal chemistry 20100513
Title: Two-pore potassium ion channels are inhibited by both G(q/11)- and G(i)-coupled P2Y receptors.
Journal: Molecular and cellular neurosciences 20100401
Title: Platelet inhibition with cangrelor.
Journal: The New England journal of medicine 20100318
Title: Platelet inhibition with cangrelor.
Journal: The New England journal of medicine 20100318
Title: Antiplatelet therapy: cangrelor for ACS-lessons from the CHAMPION trials.
Journal: Nature reviews. Cardiology 20100301
Title: Pharmacokinetic, pharmacodynamic and clinical profile of novel antiplatelet drugs targeting vascular diseases.
Journal: British journal of pharmacology 20100201
Title: The influence of variation in the P2Y12 receptor gene on in vitro platelet inhibition with the direct P2Y12 antagonist cangrelor.
Journal: Thrombosis and haemostasis 20100201
Title: Testing a new approach for rapid and reversible platelet inhibition during percutaneous coronary intervention among patients with acute coronary syndrome.
Journal: Hospital practice (1995) 20100201
Title: Emerging P2Y12 receptor antagonists: role in coronary artery disease.
Journal: Current vascular pharmacology 20100101
Title: Pharmacokinetics and pharmacodynamics of a bolus and infusion of cangrelor: a direct, parenteral P2Y12 receptor antagonist.
Journal: Journal of clinical pharmacology 20100101
Title: Prostacyclin receptor stimulation facilitates detection of human platelet P2Y(12) receptor inhibition by the PFA-100 system.
Journal: Platelets 20100101
Title: Platelet inhibition with cangrelor in patients undergoing PCI.
Journal: The New England journal of medicine 20091210
Title: Intravenous platelet blockade with cangrelor during PCI.
Journal: The New England journal of medicine 20091210
Title: Cangrelor - a champion lost in translation?
Journal: The New England journal of medicine 20091210
Title: New antiplatelet agents: why they are needed.
Journal: European journal of internal medicine 20091201
Title: Ticagrelor--a new platelet aggregation inhibitor in patients with acute coronary syndromes. An improvement of other inhibitors?
Journal: Medical science monitor : international medical journal of experimental and clinical research 20091201
Title: Cangrelor: a review on its mechanism of action and clinical development.
Journal: Expert review of cardiovascular therapy 20091001
Title: Cangrelor: a novel P2Y12 receptor antagonist.
Journal: Expert opinion on investigational drugs 20090801
Title: New P2Y12 blockers.
Journal: Journal of thrombosis and haemostasis : JTH 20090701
Title: The P2Y12 antagonists, 2-methylthioadenosine 5'-monophosphate triethylammonium salt and cangrelor (ARC69931MX), can inhibit human platelet aggregation through a Gi-independent increase in cAMP levels.
Journal: The Journal of biological chemistry 20090612
Title: Measurement of platelet P-selectin for remote testing of platelet function during treatment with clopidogrel and/or aspirin.
Journal: Platelets 20090601
Title: Mechanism of activation and functional role of protein kinase Ceta in human platelets.
Journal: The Journal of biological chemistry 20090515
Title: New antiplatelet drugs: beyond aspirin and clopidogrel.
Journal: International journal of clinical practice 20090501
Title: Streamlining the design of promising clinical trials: in-vitro testing of antithrombotic regimens and multiple agonists of platelet activation.
Journal: Coronary artery disease 20090301
Title: Advances in antiplatelet therapy: agents in clinical development.
Journal: The American journal of cardiology 20090202
Title: Cangrelor attenuates coated-platelet formation.
Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 20090101
Title: RhoA/ROCK I signalling downstream of the P2Y13 ADP-receptor controls HDL endocytosis in human hepatocytes.
Journal: Cellular signalling 20090101
Title: Current problems, new opportunities and future directions of anti-platelet therapy - increasing role of novel antiplatelet agents in cardiovascular diseases.
Journal: Recent patents on cardiovascular drug discovery 20090101
Title: Novel antiplatelet agents in development: prasugrel, ticagrelor, and cangrelor and beyond.
Journal: American journal of therapeutics 20090101
Title: Update on antiplatelet therapy in acute coronary syndromes: what do new drugs bring into clinical practice?
Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions 20090101
Title: Platelet ADP-receptor antagonists for cardiovascular disease: past, present and future.
Journal: Nature clinical practice. Cardiovascular medicine 20081201
Title: DG-041 inhibits the EP3 prostanoid receptor--a new target for inhibition of platelet function in atherothrombotic disease.
Journal: Platelets 20081201
Title: Involvement of basic amino acid residues in transmembrane regions 6 and 7 in agonist and antagonist recognition of the human platelet P2Y(12)-receptor.
Journal: Biochemical pharmacology 20081115
Title: Analysis of platelet alpha2-adrenergic receptor activity in stable coronary artery disease patients on dual antiplatelet therapy.
Journal: Thrombosis and haemostasis 20081101
Title: Future prospects in anti-platelet therapy: a review of potential P2Y12 and thrombin receptor antagonists.
Journal: Recent patents on cardiovascular drug discovery 20081101
Title: Pharmacology of emerging novel platelet inhibitors.
Journal: American heart journal 20080801
Title: Clinical overview of promising nonthienopyridine antiplatelet agents.
Journal: American heart journal 20080801
Title: Detection of P2Y(14) protein in platelets and investigation of the role of P2Y(14) in platelet function in comparison with the EP(3) receptor.
Journal: Thrombosis and haemostasis 20080801
Title: The reversible P2Y antagonist cangrelor influences the ability of the active metabolites of clopidogrel and prasugrel to produce irreversible inhibition of platelet function.
Journal: Journal of thrombosis and haemostasis : JTH 20080701
Title: Antiplatelet therapy in acute coronary syndromes.
Journal: Current cardiology reports 20080701
Title: Multiple electrode aggregometry and P2Y(12) antagonists.
Journal: Thrombosis and haemostasis 20080601
Title: Akt activation is involved in P2Y12 receptor-mediated chemotaxis of microglia.
Journal: Journal of neuroscience research 20080515
Title: P2Y12 receptors in spinal microglia are required for neuropathic pain after peripheral nerve injury.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20080507
Title: The active metabolite of prasugrel effectively blocks the platelet P2Y12 receptor and inhibits procoagulant and pro-inflammatory platelet responses.
Journal: Platelets 20080301
Title: Acyl derivatives of coenzyme A inhibit platelet function via antagonism at P2Y1 and P2Y12 receptors: a new finding that may influence the design of anti-thrombotic agents.
Journal: Platelets 20080301
Title: Transitioning patients from cangrelor to clopidogrel: pharmacodynamic evidence of a competitive effect.
Journal: Thrombosis research 20080101
Title: GPR17: molecular modeling and dynamics studies of the 3-D structure and purinergic ligand binding features in comparison with P2Y receptors.
Journal: BMC bioinformatics 20080101
Title: Enhanced platelet aggregation and activation under conditions of hypothermia.
Journal: Thrombosis and haemostasis 20071201
Title: Preliminary experience with intravenous P2Y12 platelet receptor inhibition as an adjunct to reduced-dose alteplase during acute myocardial infarction: results of the Safety, Tolerability and Effect on Patency in Acute Myocardial Infarction (STEP-AMI) angiographic trial.
Journal: American heart journal 20071001
Title: Influence of preparative procedures on assay of platelet function and apparent effects of antiplatelet agents.
Journal: The American journal of cardiology 20070815
Title: New antiplatelet therapies for acute coronary syndromes.
Journal: Current cardiology reports 20070701
Title: Inhibition of the platelet P2Y12 receptor for adenosine diphosphate potentiates the antiplatelet effect of prostacyclin.
Journal: Journal of thrombosis and haemostasis : JTH 20070301
Title: Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
Journal: Thrombosis and haemostasis 20070301
Title: Platelet P2 receptors: old and new targets for antithrombotic drugs.
Journal: Expert review of cardiovascular therapy 20070101
Title: ADP receptor antagonism: what's in the pipeline?
Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions 20070101
Title: Comparison of VASP-phosphorylation assay to light-transmission aggregometry in assessing inhibition of the platelet ADP P2Y12 receptor.
Journal: Thrombosis and haemostasis 20061201
Title: Aspirin and clopidogrel resistance: consideration and management.
Journal: Journal of interventional cardiology 20061001
Title: Effects on blood compatibility in vitro by combining a direct P2Y12 receptor inhibitor and heparin coating of stents.
Journal: Platelets 20060801
Title: Critical role of ADP interaction with P2Y12 receptor in the maintenance of alpha(IIb)beta3 activation: association with Rap1B activation.
Journal: Journal of thrombosis and haemostasis : JTH 20060601
Title: Can the PFA-100 be modified to detect P2Y12 inhibition?
Journal: Journal of thrombosis and haemostasis : JTH 20060601
Title: Cangrelor for treatment of coronary thrombosis.
Journal: The Annals of pharmacotherapy 20060501
Title: P2Y12 receptor-mediated potentiation of thrombin-induced thromboxane A2 generation in platelets occurs through regulation of Erk1/2 activation.
Journal: Journal of thrombosis and haemostasis : JTH 20060301
Title: Initial experience with an intravenous P2Y12 platelet receptor antagonist in patients undergoing percutaneous coronary intervention: results from a 2-part, phase II, multicenter, randomized, placebo- and active-controlled trial.
Journal: American heart journal 20060301
Title: Evaluation of platelet function, a method comparison.
Journal: Platelets 20060201
Title: Dependence of platelet thrombus stability on sustained glycoprotein IIb/IIIa activation through adenosine 5'-diphosphate receptor stimulation and cyclic calcium signaling.
Journal: Journal of the American College of Cardiology 20060103
Title: The nucleotide receptor P2Y13 is a key regulator of hepatic high-density lipoprotein (HDL) endocytosis.
Journal: Cellular and molecular life sciences : CMLS 20051101
Title: Glycoprotein IIb/IIIa and P2Y12 receptor antagonists yield additive inhibition of platelet aggregation, granule secretion, soluble CD40L release and procoagulant responses.
Journal: Platelets 20051101
Title: Evidence that the purinergic receptor P2Y12 potentiates platelet shape change by a Rho kinase-dependent mechanism.
Journal: Platelets 20051101
Title: Metabotropic P2Y1 receptors inhibit P2X3 receptor-channels in rat dorsal root ganglion neurons.
Journal: European journal of pharmacology 20051003
Title: P2Y12 ADP receptor-dependent tyrosine phosphorylation of proteins of 27 and 31 kDa in thrombin-stimulated human platelets.
Journal: Thrombosis and haemostasis 20050501
Title: Preclinical and clinical studies with selective reversible direct P2Y12 antagonists.
Journal: Seminars in thrombosis and hemostasis 20050401
Title: P2Y receptor antagonists in thrombosis.
Journal: Current opinion in investigational drugs (London, England : 2000) 20050301
Title: Inhibitory effects of P2Y12 receptor antagonists on TRAP-induced platelet aggregation, procoagulant activity, microparticle formation and intracellular calcium responses in patients with acute coronary syndromes.
Journal: Platelets 20050301
Title: P2Y12 receptors play a significant role in the development of platelet microaggregation in patients with diabetes.
Journal: The Journal of clinical endocrinology and metabolism 20050201
Title: Regulation of tissue factor-induced coagulation and platelet aggregation in flowing whole blood.
Journal: Thrombosis and haemostasis 20050101
Title: Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases.
Journal: Journal of thrombosis and haemostasis : JTH 20050101
Title: Potentiation of platelet aggregation by heparin in human whole blood is attenuated by P2Y12 and P2Y1 antagonists but not aspirin.
Journal: Thrombosis research 20050101
Title: Investigation of the PADA as a method for monitoring GPIIb/IIIa inhibitors and other antiplatelet agents.
Journal: Seminars in thrombosis and hemostasis 20050101
Title: Autoinhibition of transmitter release from PC12 cells and sympathetic neurons through a P2Y receptor-mediated inhibition of voltage-gated Ca2+ channels.
Journal: The European journal of neuroscience 20041201
Title: P2Y12 receptor stimulation inhibits beta-adrenergic receptor-induced differentiation by reversing the cyclic AMP-dependent inhibition of protein kinase B.
Journal: Journal of neurochemistry 20040401
Title: Costimulation of the Gi-coupled ADP receptor and the Gq-coupled TXA2 receptor is required for ERK2 activation in collagen-induced platelet aggregation.
Journal: FEBS letters 20040102
Title: Inhibition of ADP-induced intracellular Ca2+ responses and platelet aggregation by the P2Y12 receptor antagonists AR-C69931MX and clopidogrel is enhanced by prostaglandin E1.
Journal: Cell calcium 20040101
Title: Pharmacodynamic profile of antiplatelet agents: marked differences between single versus costimulation with platelet activators.
Journal: Thrombosis research 20040101
Title: Differential involvement of the P2Y1 and P2Y12 receptors in platelet procoagulant activity.
Journal: Arteriosclerosis, thrombosis, and vascular biology 20031001
Title: Potential value of triple antiplatelet therapy for secondary stroke prevention.
Journal: Stroke 20031001
Title: Effects of inhibition of P2Y(1) and P2Y(12) on whole blood clotting, coagulum elasticity and fibrinolysis resistance studied with free oscillation rheometry.
Journal: Thrombosis research 20030315
Title: In vivo blockade of platelet ADP receptor P2Y12 reduces embolus and thrombus formation but not thrombus stability.
Journal: Arteriosclerosis, thrombosis, and vascular biology 20030301
Title: Advantages of fast-acting ADP receptor blockade in ischemic heart disease.
Journal: Arteriosclerosis, thrombosis, and vascular biology 20030201
Title: Blockade of the platelet P2Y12 receptor by AR-C69931MX sustains coronary artery recanalization and improves the myocardial tissue perfusion in a canine thrombosis model.
Journal: Arteriosclerosis, thrombosis, and vascular biology 20030201
Title: A selective role for phosphatidylinositol 3,4,5-trisphosphate in the Gi-dependent activation of platelet Rap1B.
Journal: The Journal of biological chemistry 20030103
Title: The effects of GPIIb-IIIa antagonists and a combination of three other antiplatelet agents on platelet-leukocyte interactions.
Journal: Current medical research and opinion 20030101
Title: Effects of the NHE-1 inhibitor cariporide alone or together with the P2Y12 antagonist AR-C 69331 MX on CD62p expression and formation of platelet-leukocyte aggregates.
Journal: Thrombosis research 20030101
Title: Agonist concentration-dependent differential responsivity of a human platelet purinergic receptor: pharmacological and kinetic studies of aggregation, deaggregation and shape change responses mediated by the purinergic P2Y1 receptor in vitro.
Journal: Platelets 20030101
Title: Comparison of the pharmacodynamic effects of the platelet ADP receptor antagonists clopidogrel and AR-C69931MX in patients with ischaemic heart disease.
Journal: Platelets 20021101
Title: Inhibition of ADP-induced P-selectin expression and platelet-leukocyte conjugate formation by clopidogrel and the P2Y12 receptor antagonist AR-C69931MX but not aspirin.
Journal: Thrombosis and haemostasis 20020901
Title: Functional significance of adenosine 5'-diphosphate receptor (P2Y(12)) in platelet activation initiated by binding of von Willebrand factor to platelet GP Ibalpha induced by conditions of high shear rate.
Journal: Circulation 20020528
Title: Safety profile and tolerability of intravenous AR-C69931MX, a new antiplatelet drug, in unstable angina pectoris and non-Q-wave myocardial infarction.
Journal: Clinical therapeutics 20020501
Title: A Gi-dependent pathway is required for activation of the small GTPase Rap1B in human platelets.
Journal: The Journal of biological chemistry 20020405
Title: Role of ADP receptor P2Y(12) in platelet adhesion and thrombus formation in flowing blood.
Journal: Arteriosclerosis, thrombosis, and vascular biology 20020401
Title: Role of the PAR4 thrombin receptor in stabilizing platelet-platelet aggregates as revealed by a patient with Hermansky-Pudlak syndrome.
Journal: Thrombosis and haemostasis 20020401
Title: Differential regulation of Rho and Rac through heterotrimeric G-proteins and cyclic nucleotides.
Journal: The Journal of biological chemistry 20011221
Title: Blockade of adenosine diphosphate receptors P2Y(12) and P2Y(1) is required to inhibit platelet aggregation in whole blood under flow.
Journal: Blood 20011201
Title: Effects of combining three different antiplatelet agents on platelets and leukocytes in whole blood in vitro.
Journal: British journal of pharmacology 20010901
Title: Extracellular ATP or ADP induce chemotaxis of cultured microglia through Gi/o-coupled P2Y receptors.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20010315
Title: Activation of Gi-coupled receptors releases a tonic state of inhibited platelet aggregation.
Journal: Platelets 20010301
Title: Open multicentre study of the P2T receptor antagonist AR-C69931MX assessing safety, tolerability and activity in patients with acute coronary syndromes.
Journal: Thrombosis and haemostasis 20010301
Title: ADP receptor antagonists inhibit platelet aggregation induced by the chemokines SDF-1, MDC and TARC.
Journal: FEBS letters 20010209
Title: Cangrelor AstraZeneca.
Journal: Current opinion in investigational drugs (London, England : 2000) 20010201
Title: The medicinal chemistry of the P2 receptor family.
Journal: Progress in medicinal chemistry 20010101
Title: Bhattad VB, , et al. Intravenous cangrelor as a peri-procedural bridge with applied uses in ischemic events. Ann Transl Med. 2019;7(17):408.
Title: Zhan T, Wei T, et al. Cangrelor alleviates bleomycin-induced pulmonary fibrosis by inhibiting platelet activation in mice. Mol Immunol. 2020;120:83-92.
Title: Bekő K, et al. Contribution of platelet P2Y12 receptors to chronic Complete Freund's adjuvant-induced inflammatory pain. J Thromb Haemost. 2017;15(6):1223-1235.
